Genentech

Advancements in colon and rectal cancer treatments

2 clusters · 8 sources · last updated about 19 hours ago

Latest: Advancements in rectal and colon cancer treatment and monitoring

Recent medical developments have introduced new approaches for the treatment and monitoring of rectal and colon cancers, specifically regarding immunotherapy and DNA monitoring. The U.S. Food and Drug Administration app

Clinical developments in obesity and diabetes medications

2 clusters · 12 sources · last updated 4 days ago

Latest: Zealand Pharma reports positive Phase 2 results for obesity drug petrelintide

Pharmaceutical developments regarding experimental treatments for obesity and type 2 diabetes have shown positive results in Phase II clinical trials. In late September 2026, Roche and Genentech reported successful Phas

Pancreatic cancer treatment and care advancements

2 clusters · 10 sources · last updated 5 days ago

Latest: Pancreatic cancer research and care models see new developments

Developments in pancreatic cancer treatment are focusing on both clinical immunotherapy breakthroughs and improved healthcare delivery models. Clinical research has highlighted the potential of cancer vaccines to train

AI-driven drug discovery and regulatory integration

17 clusters · 53 sources · last updated 7 days ago

Latest: Biopharmaceutical leaders call for European investment and AI oversight

By late September 2026, the pharmaceutical industry has transitioned from pilot programs to full-scale execution, focusing on integrating AI with real-time experimental data to create a ‘data closed loop’. Major partners

FDA priority reviews for new medical therapies

2 clusters · 5 sources · last updated 12 days ago

Latest: Roche's fenebrutinib receives FDA priority review for multiple sclerosis

The U.S. Food and Drug Administration (FDA) has granted priority review to several new investigational therapies for various medical conditions. In late September 2026, the FDA granted priority review to Bayer’s elinzan